Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
It is described in the literature a higher prevalence of pain in patients with an addiction but there are few studies describing the pain profile of patients with use disorder.
Pain has a very negative impact on the quality of life of opioid substituted patients. Improving knowledge on this point would make it possible to better guide specific care.
The investigator proposes to conduct a single-center descriptive observational study using questionnaires, without changing the management of patients with chronic pain.
The primary objective of the study is to determine the prevalence of chronic pain in patients with substance addiction hospitalized for addiction treatment.
It is described in the literature a higher prevalence of pain in patients with an addiction but there are few studies describing the pain profile of patients with use disorder.
Pain has a very negative impact on the quality of life of opioid substituted patients. Improving knowledge on this point would make it possible to better guide specific care.
The investigator proposes to conduct a single-center descriptive observational study using questionnaires, without changing the management of patients with chronic pain. All patients admitted to hospitalization in the addiction department of the LORIENT Hospital will be offered participation in the study.
The primary objective of the study is to determine the prevalence of chronic pain in patients with substance addiction hospitalized for addiction treatment.
The study will also evaluate the impact on daily activities of the presence of two chronic pathologies: chronic pain and addiction, describe the frequency of the two main psychiatric comorbidities of chronic pain: anxiety and depression, describe the different components of chronic pain in patients with substance addiction, and get information on analgesic medications.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence of chronic pain in patients with substance addiction hospitalized for addiction treatment. | Percentage of patients presenting with pain for more than three months among patients hospitalized in an addiction service for the management of an addiction | During the hospitalization, maximum 1 month |
| Measure | Description | Time Frame |
|---|---|---|
| Pain intensity in the last 24 hours | Results of the Brief Pain Inventory : worst and least of pain in the last 24 hours | During the hospitalization, maximum 1 month |
| Interference of pain on the quality of life |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients hospitalized in the addictology department of LORIENT Hospital, in full hospitalization or in a day hospital
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Alexandre Cauchie, MD | GH Bretagne Sud | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Groupe Hospitalier Bretagne Sud | Lorient | 56100 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 12746360 | Background | Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003 May 14;289(18):2370-8. doi: 10.1001/jama.289.18.2370. | |
| 24284850 | Background | Lusted A, Roerecke M, Goldner E, Rehm J, Fischer B. Prevalence of pain among nonmedical prescription opioid users in substance use treatment populations: systematic review and meta-analyses. Pain Physician. 2013 Nov-Dec;16(6):E671-84. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D059350 | Chronic Pain |
| D016739 | Behavior, Addictive |
| ID | Term |
|---|---|
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Result of Brief pain inventory on general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. On a scale from 0 (does not interfere) to 10 (completely interferes)
| During the hospitalization, maximum 1 month |
| Localisation of pain | Drawing on a diagram of a human body | During the hospitalization, maximum 1 month |
| Describe the frequency of the two main psychiatric comorbidities of chronic pain: anxiety | Results of the anxiety scale of Hospital Anxiety and Depression scale. Positive if > 8. Minimum 0, maximum 21 | During the hospitalization, maximum 1 month |
| Describe the frequency of the two main psychiatric comorbidities of chronic pain: depression | Results of the depression scale of Hospital Anxiety and Depression scale. Positive if > 8. Minimum 0, maximum 21 | During the hospitalization, maximum 1 month |
| Describe the prevalence of fibromyalgia among patients with substance addiction | Results of the Fibromyalgia Rapid Screening Tool. Suspicion of fibromyalgia if >5 yes. Maximum 6 yes | During the hospitalization, maximum 1 month |
| Information on analgesics medication | Collection of current analgesic medication taken every day | During the hospitalization, maximum 1 month |
| Describe the prevalence of neuropathic pain among patients with substance addiction | Results of the DN3 (neuropathic pain 3). Suspicion of neuropathic pain when > 3/7 | During the hospitalization, maximum 1 month |
| 16095934 | Background | Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006 May;10(4):287-333. doi: 10.1016/j.ejpain.2005.06.009. Epub 2005 Aug 10. |
| 29976203 | Background | Voon P, Greer AM, Amlani A, Newman C, Burmeister C, Buxton JA. Pain as a risk factor for substance use: a qualitative study of people who use drugs in British Columbia, Canada. Harm Reduct J. 2018 Jul 5;15(1):35. doi: 10.1186/s12954-018-0241-y. |
| 17506152 | Background | Larson MJ, Paasche-Orlow M, Cheng DM, Lloyd-Travaglini C, Saitz R, Samet JH. Persistent pain is associated with substance use after detoxification: a prospective cohort analysis. Addiction. 2007 May;102(5):752-60. doi: 10.1111/j.1360-0443.2007.01759.x. |
| D003192 | Compulsive Behavior |
| D007175 | Impulsive Behavior |
| D001519 | Behavior |